Healthline: What we know about Eli Lilly’s experimental weight-loss drug

UC expert says weight loss often doesn’t last long term

According to drugmaker Eli Lilly, participants in a clinical trial lost over 50 pounds on average when they were treated with the highest dose of a new hunger suppressant.

The drug, called tirzepatide, is making headlines, but has not yet been approved or authorized by the Food and Drug Administration. Additionally, the initial research has been made public by the drug maker Eli Lilly and has not yet been published in a peer-reviewed medical journal.

In a story on the drug published by Healthline, one of the experts quoted is Shailendra Patel, MD, PhD, Division of Endocrinology, Diabetes and Metabolism in the Department of Internal Medicine at the UC College of Medicine.

Dr.Shailendra Patel in his Reading lab.

Shailendra Patel, MD, PhD, Division of Endocrinology, Diabetes and Metabolism at the UC College of Medicine/Photo/Colleen Kelley/UC Creative + Brand

Patel told Healthline that approaches to weight loss have typically involved dieting but that diets often result only in short term weight loss because they are extremely difficult to stick with for an indefinite period of time.

“The reason that all these diets fail is that human beings cannot stick with any one of these diet plans forever,” he said.

Patel points out that due to the complexity of obesity relying on a single solution, whether a diet or a pill, is likely not going to work long term.

“We have yet another weight loss drug to help patients," said Patel. “But drugs by themselves, just like crash diets by themselves, you can see weight loss – but you won’t be successful.”

He said if people with obesity want to lose weight it may require multiple interventions some of which may include medical interventions.

Patel pointed out that even bariatric surgery, which involves shrinking or bypassing the stomach through surgery, requires patients to change their long-term approach to diet and exercise for the best results.

See the entire story here

Lead photo/Darron Cummings/AP

Impact Lives Here

The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.

Related Stories


Residents concerned about high concentration of low-income...

May 16, 2024

Efforts to build more affordable housing in Cincinnati have created concerns for residents as low-income housing has been concentrated in some of the city’s poorest neighborhoods, WCPO reported. Gary Painter, PhD, the academic director of the University of Cincinnati’s Carl H. Lindner College of Business real estate program and a professor of real estate, said a complaint against the city could lead to positive outcomes.

Debug Query for this